Bayer: Strong growth, guidance upgrade
The Pharma Data
AUGUST 5, 2021
Earnings were also diminished by a negative product mix, currency effects of 111 million euros, and the later receipt of license revenues. and from a strong allergy season in North America, which resulted in a 15.8 in sales in the Allergy & Cold category. Pharmaceuticals raises sales and earnings. to 4.494 billion euros.
Let's personalize your content